Substance or medication-induced depressive disorder: Difference between revisions
Kiran Singh (talk | contribs) Created page with "__NOTOC__ {{SI}} {{CMG}} {{AE}} {{KS}} ==Overview== ==References== {{Reflist|1}} Category:DSM-V Diagnostic Criteria Category:Psychiatric Disease Category:Ps..." |
Rohit reddy (talk | contribs) |
||
(20 intermediate revisions by 4 users not shown) | |||
Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{ | {{Clinical depression}} | ||
{{CMG}} {{AE}} {{KS}} | {{CMG}}; {{AE}} {{KS}} | ||
==Overview== | ==Overview== | ||
Substance-induced depressive disorder is characterized by a persistent depressed mood that developed during or after substance intoxication or withdrawal or after exposure to a medication. | |||
==Differential Diagnosis== | |||
Substance- or medication-induced depression must be differentiated from: | |||
*[[Depressive disorder]] due to another medical condition | |||
*Primary [[depressive disorder]] | |||
*Substance intoxication and withdrawal<ref name=DSMV>{{cite book | title = Diagnostic and statistical manual of mental disorders : DSM-5 | publisher = American Psychiatric Association | location = Washington, D.C | year = 2013 | isbn = 0890425558 }}</ref> | |||
==Epidemiology and Demographics== | |||
===Prevalence=== | |||
The prevalence of substance or medication-induced [[Clinical depression|depressive disorder]] is 260 per 100,000 (0.26%) of the overall population.<ref name=DSMV>{{cite book | title = Diagnostic and statistical manual of mental disorders : DSM-5 | publisher = American Psychiatric Association | location = Washington, D.C | year = 2013 | isbn = 0890425558 }}</ref> | |||
==Risk Factors== | |||
Risk factors for the development of substance- or medication-induced depressive disorder include: | |||
*[[Antisocial behavior]] | |||
*[[Alcohol]] or drug use disorders | |||
*Family history of substance use disorders | |||
*History of drug induced [[depression]] | |||
*History of stressful life events | |||
*History of [[major depressive disorder]] | |||
*Psychosocial stressors | |||
*Specific type of medication | |||
:*Effavirenz | |||
:*High [[estrogen]]/[[Progesterone]] in OCP | |||
:*[[Interferon alpha]] | |||
:*[[Prednisone]]<ref name=DSMV>{{cite book | title = Diagnostic and statistical manual of mental disorders : DSM-5 | publisher = American Psychiatric Association | location = Washington, D.C | year = 2013 | isbn = 0890425558 }}</ref> | |||
==Diagnostic Criteria== | |||
===DSM-V Diagnostic Criteria for Substance/Medication-Induced Depressive Disorder <ref name=DSMV>{{cite book | title = Diagnostic and statistical manual of mental disorders : DSM-5 | publisher = American Psychiatric Association | location = Washington, D.C | year = 2013 | isbn = 0890425558 }}</ref>=== | |||
{{cquote| | |||
*A. A prominent and persistent disturbance in mood that predominates in the clinical picture and is characterized by [[Clinical depression|depressed mood]] or markedly diminished interest or pleasure in all, or almost all, activities. | |||
'''''AND''''' | |||
*B. There is evidence from the history, physical examination, or laboratory findings of both (1) and (2): | |||
:*1. The symptoms in Criterion A developed during or soon after substance intoxication or withdrawal or after exposure to a medication. | |||
:*2. The involved substance/medication is capable of producing the symptoms in Criterion A. | |||
'''''AND''''' | |||
*C. The disturbance is not better explained by a [[depressive disorder]] that is not substance/medication-induced. Such evidence of an independent [[depressive disorder]] could include the following: | |||
:* The symptoms preceded the onset of the substance/medication use; the symptoms persist for a substantial period of time (e.g., about 1 month) after the cessation of acute withdrawal or severe intoxication; or there is other evidence suggesting the existence of an independent non-substance/medication-induced [[depressive disorder]] (e.g., a history of recurrent non-substance/medication-related episodes). | |||
'''''AND''''' | |||
*D. The disturbance does not occur exclusively during the course of a [[delirium]]. | |||
'''''AND''''' | |||
*E. The disturbance causes clinically significant distress or impairment in social, occupational,or other important areas of functioning. | |||
<SMALL>''Note: This diagnosis should be made instead of a diagnosis of substance intoxication or substance withdrawal only when the symptoms in Criterion A predominate in the clinical picture and when they are sufficiently severe to warrant clinical attention.''</SMALL> | |||
}} | |||
==References== | ==References== |
Latest revision as of 19:30, 23 August 2021
Clinical Depression Microchapters |
Diagnosis |
---|
Treatment |
Follow-up |
Case Studies |
Substance or medication-induced depressive disorder On the Web |
American Roentgen Ray Society Images of Substance or medication-induced depressive disorder |
Substance or medication-induced depressive disorder in the news |
Blogs on Substance or medication-induced depressive disorder |
Risk calculators and risk factors for Substance or medication-induced depressive disorder |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Kiran Singh, M.D. [2]
Overview
Substance-induced depressive disorder is characterized by a persistent depressed mood that developed during or after substance intoxication or withdrawal or after exposure to a medication.
Differential Diagnosis
Substance- or medication-induced depression must be differentiated from:
- Depressive disorder due to another medical condition
- Primary depressive disorder
- Substance intoxication and withdrawal[1]
Epidemiology and Demographics
Prevalence
The prevalence of substance or medication-induced depressive disorder is 260 per 100,000 (0.26%) of the overall population.[1]
Risk Factors
Risk factors for the development of substance- or medication-induced depressive disorder include:
- Antisocial behavior
- Alcohol or drug use disorders
- Family history of substance use disorders
- History of drug induced depression
- History of stressful life events
- History of major depressive disorder
- Psychosocial stressors
- Specific type of medication
- Effavirenz
- High estrogen/Progesterone in OCP
- Interferon alpha
- Prednisone[1]
Diagnostic Criteria
DSM-V Diagnostic Criteria for Substance/Medication-Induced Depressive Disorder [1]
“ |
AND
AND
AND
AND
Note: This diagnosis should be made instead of a diagnosis of substance intoxication or substance withdrawal only when the symptoms in Criterion A predominate in the clinical picture and when they are sufficiently severe to warrant clinical attention. |
” |